Role of Antiplatelet/Anticoagulant Medications and Blood-Clotting Tests in Prediction of Traumatic Foot Compartment Syndrome

Young Hwan Park, Won Seok Choi, Gi Won Choi, Hak Jun Kim

Research output: Contribution to journalArticle

Abstract

Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7%) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.

Original languageEnglish
JournalFoot and Ankle International
DOIs
Publication statusAccepted/In press - 2018 Mar 1

Fingerprint

Compartment Syndromes
Hematologic Tests
Blood Coagulation
Anticoagulants
Foot
Foot Injuries
Platelet Aggregation Inhibitors
Hemostatics
Logistic Models
Regression Analysis
Hemorrhage

Keywords

  • anticoagulant
  • antiplatelet
  • blood-clotting test
  • foot compartment syndrome

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Role of Antiplatelet/Anticoagulant Medications and Blood-Clotting Tests in Prediction of Traumatic Foot Compartment Syndrome. / Park, Young Hwan; Choi, Won Seok; Choi, Gi Won; Kim, Hak Jun.

In: Foot and Ankle International, 01.03.2018.

Research output: Contribution to journalArticle

@article{85278d0938c14243a23a9436e327dcc9,
title = "Role of Antiplatelet/Anticoagulant Medications and Blood-Clotting Tests in Prediction of Traumatic Foot Compartment Syndrome",
abstract = "Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7{\%}) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.",
keywords = "anticoagulant, antiplatelet, blood-clotting test, foot compartment syndrome",
author = "Park, {Young Hwan} and Choi, {Won Seok} and Choi, {Gi Won} and Kim, {Hak Jun}",
year = "2018",
month = "3",
day = "1",
doi = "10.1177/1071100718757956",
language = "English",
journal = "Foot and Ankle International",
issn = "1071-1007",
publisher = "AOFAS - American Orthopaedic Foot and Ankle Society",

}

TY - JOUR

T1 - Role of Antiplatelet/Anticoagulant Medications and Blood-Clotting Tests in Prediction of Traumatic Foot Compartment Syndrome

AU - Park, Young Hwan

AU - Choi, Won Seok

AU - Choi, Gi Won

AU - Kim, Hak Jun

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7%) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.

AB - Background: Although intracompartmental bleeding is one cause of traumatic compartment syndrome, no previous studies have defined the role of hemostatic stability in the development of traumatic compartment syndrome. Therefore, to investigate this issue, we identified the relationship between antiplatelet/anticoagulant medications and the development of traumatic foot compartment syndrome. In addition, as a possible predictor of compartment syndrome, we evaluated the utility of blood-clotting tests in the prediction of traumatic foot compartment syndrome. Methods: Retrospective review of patients diagnosed with isolated foot injury in our institution between 2008 and 2016 was used to identify patients who had traumatic foot compartment syndrome. Potential predictors, including medication history for antiplatelet/anticoagulant agents and blood-clotting test results, were analyzed using logistic regression analysis. The present study included 789 feet, and 29 (3.7%) had traumatic foot compartment syndrome. Results: The antiplatelet medication and the blood-clotting test results were not significantly associated with the development of traumatic foot compartment syndrome. Among other variables, damage caused by heavy objects as the injury mechanism was the only significant predictor in the development of traumatic foot compartment syndrome (P <.05). Conclusion: Our results showed that antiplatelet medication and blood-clotting tests did not predict the development of traumatic foot compartment syndrome. Level of Evidence: Level III, retrospective comparative series.

KW - anticoagulant

KW - antiplatelet

KW - blood-clotting test

KW - foot compartment syndrome

UR - http://www.scopus.com/inward/record.url?scp=85044055239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044055239&partnerID=8YFLogxK

U2 - 10.1177/1071100718757956

DO - 10.1177/1071100718757956

M3 - Article

JO - Foot and Ankle International

JF - Foot and Ankle International

SN - 1071-1007

ER -